USPTO serial 79031580
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey R. Halpern
STACEY R. HALPERN KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET14TH FLOORIRVINE, CA 92614| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PRODUCTS, NAMELY, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; VETERINARY PRODUCTS, NAMELY, VETERINARY PREPARATIONS FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; SANITARY PREPARATIONS FOR MEDICAL PURPOSES; DIETETIC FOODS ADAPTED FOR MEDICAL USE; ADJUVANTS FOR MEDICAL PURPOSES, NAMELY, RECOMBINANT PROTEINS AND VACCINES FOR HUMAN AND VETERINARY USE; AMINO ACIDS FOR MEDICAL PURPOSES; ANESTHETICS, NAMELY ANESTHETICS FOR SURGICAL AND NON-SURGICAL USE; ANALGESICS; VERMIFUGES; ANTIBIOTICS; BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES, NAMELY BIOLOGICAL PREPARATIONS TO PRODUCE MEDICINES FOR HUMAN OR VETERINARY USE; CHEMICAL PREPARATIONS FOR PHARMACEUTICAL PURPOSES, NAMELY, BISMUTH PREPARATIONS FOR PHARMACEUTICAL PURPOSES, POTASSIUM PREPARATIONS FOR PHARMACEUTICAL PURPOSES; CHEMICAL REAGENTS FOR MEDICAL OR VETERINARY PURPOSES; CHEMICAL-PHARMACEUTICAL PREPARATIONS, NAMELY, CHEMICAL PREPARATIONS FOR SANITARY USE, PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY; FERMENTS FOR MEDICAL OR VETERINARY USE; HORMONES FOR MEDICAL PURPOSES; MEDICAL INFUSIONS IN THE NATURE OF PLANT EXTRACTS FOR MEDICAL AND VETERINARY PURPOSES; MEDICINES FOR DENTAL PURPOSES, NAMELY TOPICAL AND SURGICAL ANESTHETICS; MEDICINES FOR HUMAN PURPOSES, NAMELY, MEDICINES FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; PHARMACEUTICAL PREPARATIONS, NAMELY, FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; PILLS FOR PHARMACEUTICAL PURPOSES, NAMELY, PILLS CONTAINING PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR THE TREATMENT OF CANCER, OPHTHALMIC, CARDIOVASCULAR, NEUROLOGICAL, RESPIRATORY, DIGESTIVE AND INFLAMMATORY DISEASE; RADIOLOGICAL CONTRAST MEDIA FOR MEDICAL PURPOSES; STEROIDS | SECTION 71 - CANCELLED | — |
| 042 | SCIENTIFIC AND TECHNOLOGICAL SERVICES, NAMELY, SCIENTIFIC RESEARCH, TECHNOLOGY CONSULTATION AND RESEARCH, ALL IN THE FIELD OF CHEMICO-PHARMACEUTICAL PREPARATIONS; INDUSTRIAL ANALYSIS AND RESEARCH SERVICES IN THE FIELD OF CHEMICO-PHARMACEUTICAL PREPARATIONS; LEGAL SERVICES; BIOLOGICAL RESEARCH; CHEMICAL ANALYSIS; CHEMICAL RESEARCH; CHEMISTRY SERVICES, NAMELY CHEMISTRY CONSULTATION, RESEARCH IN THE FIELD OF CHEMISTRY; QUALITY CONTROL FOR OTHERS IN THE FIELD OF HUMAN AND VETERINARY PHARMACEUTICAL PREPARATIONS; INTELLECTUAL PROPERTY CONSULTANCY; LICENSING OF INTELLECTUAL PROPERTY; QUALITY CONTROL FOR OTHERS; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS FOR THIRD PARTIES | SECTION 71 - CANCELLED | — |
| 044 | MEDICAL SERVICES, VETERINARY SERVICES | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 20, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Sep 20, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 26, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 24, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 1, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 1, 2015 | INPC | INVALIDATION PROCESSED | — |
| Aug 5, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 3, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 5, 2014 | C71T | CANCELLED SECTION 71 | — |
| Apr 14, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 26, 2012 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 18, 2009 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 31, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 31, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 15, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 15, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 29, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 9, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 22, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 22, 2007 | ALIE | ASSIGNED TO LIE | — |
| Nov 13, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 13, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 13, 2007 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 13, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 13, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 11, 2007 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 11, 2007 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 11, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 19, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2007 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2007 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 5, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 20, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 20, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 17, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 16, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 14, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |